Your browser doesn't support javascript.
loading
Prognostic models for patients with metastatic urothelial carcinoma: why use them?
Maffezzoli, Michele; Campobasso, Davide; Rebuzzi, Sara E; Banna, Giuseppe L; Fornarini, Giuseppe; Signori, Alessio; Rescigno, Pasquale; Buti, Sebastiano.
Afiliação
  • Maffezzoli M; Unit of Medical Oncology, University Hospital of Parma, Parma, Italy - michele.maffezzoli@unipr.it.
  • Campobasso D; Department of Urology, University Hospital of Parma, Parma, Italy.
  • Rebuzzi SE; Unit of Medical Oncology, San Paolo Hospital, Savona, Italy.
  • Banna GL; Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa, Genoa, Italy.
  • Fornarini G; Department of Oncology, Portsmouth Hospitals University NHS Trust, Portsmouth, UK.
  • Signori A; Unit of Medical Oncology, IRCCS San Martino University Hospital, Genoa, Italy.
  • Rescigno P; Section of Biostatistics, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
  • Buti S; Center for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.
Minerva Urol Nephrol ; 75(4): 419-421, 2023 08.
Article em En | MEDLINE | ID: mdl-37166132
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Neoplasias Urológicas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Neoplasias Urológicas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article